Technical Analysis for ANIK - Anika Therapeutics Inc.

Grade Last Price % Change Price Change
C 25.54 0.71% 0.18
ANIK closed up 0.71 percent on Wednesday, March 27, 2024, on 66 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
20 DMA Resistance Bearish 0.71%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.71%
Narrow Range Bar Range Contraction 0.71%
Outside Day Range Expansion 0.71%
Fell Below 20 DMA Bearish 1.79%
Narrow Range Bar Range Contraction 1.79%
Crossed Above 20 DMA Bullish 0.31%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 15 hours ago
60 Minute Opening Range Breakout about 16 hours ago
20 DMA Support about 19 hours ago
Rose Above 20 DMA about 19 hours ago
Non-ADX 1,2,3,4 Pullback Entry about 19 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Anika Therapeutics Inc. Description

Anika Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its products are based on hyaluronic acid (HA), a naturally occurring biocompatible polymer found in the body. The company's products include ORTHOVISC, ORTHOVISC mini, and MONOVISC for the treatment of osteoarthritis of the knee and various other joints; Hyalofast, a biodegradable support for human bone marrow mesenchymal stem cells that is used in connection with soft tissue regeneration; Hyalonect, a woven gauze used as a graft wrap; Hyaloss, HYAFF fibers used to mix blood/bone grafts to form a paste for bone regeneration; and Hyaloglide, an ACP gel used in tenolysis treatment. It also provides wound care products that comprise Hyalomatrix and Hyalofill, for treatment of complex wounds, such as burns and ulcers; and Hyalograft 3D and Laserskin scaffolds for use in connection with the regeneration of skin, as well as ELEVESS, an aesthetic dermatology product for facial wrinkles and scar remediation. In addition, the company offers AMVISC, AMVISC Plus, STAARVISC-II, Optivisc, AnikaVisc, and AnikaVisc Plus that are injectable HA products used as viscoelastic agents in ophthalmic surgical procedures, such as cataract extraction and intraocular lens implantation. Further, it provides Hyalobarrier, a post-operative adhesion barrier; INCERT, a HA product for the prevention of spinal post-surgical adhesions; and Merogel, a woven fleece nasal packing, as well as Merogel Injectable, a viscous hydrogel. Additionally, the company offers HYVISC, an injectable HA product used for the treatment of joint dysfunction in horses. Anika Therapeutics, Inc. markets its products directly, as well as through a network of distributors in the United States, Europe, and internationally. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Acid Laser Stem Cell Bone Ophthalmic Therapeutic Products Dermatology Dysfunction Wound Knee Ulcer Osteoarthritis Healing Burns Bone Marrow Cataracts Wrinkle Bone Grafting Hyaluronic Acid Intraocular Lens Mesenchymal Stem Cell Treatment Of Osteoarthritis Wound Care Products Oral And Maxillofacial Surgery Scar Glycosaminoglycans Joint Dysfunction Therapeutic

Is ANIK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 29.23
52 Week Low 16.57
Average Volume 87,167
200-Day Moving Average 22.17
50-Day Moving Average 24.51
20-Day Moving Average 25.43
10-Day Moving Average 25.31
Average True Range 0.99
RSI (14) 54.55
ADX 27.93
+DI 16.82
-DI 26.09
Chandelier Exit (Long, 3 ATRs) 24.33
Chandelier Exit (Short, 3 ATRs) 23.97
Upper Bollinger Bands 26.36
Lower Bollinger Band 24.50
Percent B (%b) 0.56
BandWidth 7.31
MACD Line 0.23
MACD Signal Line 0.31
MACD Histogram -0.0772
Fundamentals Value
Market Cap 373.93 Million
Num Shares 14.6 Million
EPS -1.68
Price-to-Earnings (P/E) Ratio -15.20
Price-to-Sales 2.15
Price-to-Book 1.30
PEG Ratio 3.19
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 26.04
Resistance 3 (R3) 26.04 25.89 25.95
Resistance 2 (R2) 25.89 25.76 25.88 25.92
Resistance 1 (R1) 25.71 25.68 25.80 25.71 25.90
Pivot Point 25.56 25.56 25.60 25.55 25.56
Support 1 (S1) 25.38 25.43 25.47 25.38 25.18
Support 2 (S2) 25.23 25.35 25.22 25.16
Support 3 (S3) 25.05 25.23 25.13
Support 4 (S4) 25.05